THOP1
THOP1 (thimet oligopeptidase 1) is a zinc-dependent oligopeptidase of the peptidase M3 family that degrades short peptides in the cytoplasm. It acts on neuropeptides under 20 amino acids long and contributes to cytosolic peptide turnover. Browse Assay Genie's current range of THOP1 research reagents below, or read on for the biology behind the target.
THOP1 is a cytoplasmic oligopeptidase that takes part in the metabolism of neuropeptides shorter than 20 amino acid residues and in general cytoplasmic peptide degradation. NCBI describes the encoded protein as a kininase that uses zinc as a cofactor. By cleaving cytosolic peptides, it makes them unavailable for display on antigen-presenting cells, which links the enzyme to peptide handling upstream of antigen presentation.
The enzyme also regulates cannabinoid signalling. It mediates degradation of hemopressin, a peptide antagonist of the cannabinoid receptor CNR1, so changes in THOP1 activity can influence how much of this antagonist is available. In addition, THOP1 can degrade the amyloid-beta precursor protein and generate amyloidogenic fragments, which is why it appears in studies of amyloid biology.
The human THOP1 gene encodes thimet oligopeptidase, classified under EC 3.4.24.15 and assigned to the M3 metallopeptidase family. Mouse and rat both carry a Thop1 ortholog, so rodent models can be used to study its function. Researchers working with THOP1 commonly examine the THOP1 protein by immunodetection or quantify it in lysates, for example with a THOP1 antibody or THOP1 ELISA kit, to follow expression in studies of neuropeptide processing, antigen handling and amyloid-related pathways.
THOP1 participates in the metabolism of neuropeptides under 20 amino acids long, making it a point of interest for peptide turnover studies.
The enzyme is involved in cytoplasmic peptide degradation, cleaving cytosolic peptides before they can be displayed on antigen-presenting cells.
THOP1 degrades hemopressin, an antagonist peptide of the cannabinoid receptor CNR1, and so regulates this signalling pathway.
THOP1 can degrade the amyloid-beta precursor protein and generate amyloidogenic fragments, relevant to research on amyloid peptide production.
THOP1 is a zinc-dependent oligopeptidase that degrades peptides in the cytoplasm, including neuropeptides under 20 amino acids long. It also degrades hemopressin, regulating CNR1 cannabinoid signalling, and can cleave amyloid-beta precursor protein to amyloidogenic fragments.
The HGNC name is thimet oligopeptidase 1, and UniProt lists the protein as thimet oligopeptidase. No alternative aliases or previous symbols are recorded. It belongs to the peptidase M3 family and carries the EC number 3.4.24.15.
Yes. Both mouse and rat have an ortholog named Thop1, so rodent systems can be used to study the enzyme. Reactivity differs between reagents, so check the datasheet of any product for its validated reactivity.
Receptor and substrate targets linked to THOP1 function, including cannabinoid signalling and amyloid precursor processing.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P52888; product specifications from Assay Genie datasheets.